Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Best Of The IN VIVO Blog (06/2010)

This article was originally published in Start Up

Executive Summary

Best of the blog is a monthly column highlighting the best of our free online content at www.windhover.com/blog.

You may also be interested in...



Biotech Tax Credit Guidelines Clarify That All Qualifiers Will Receive An Award

IRS guidance for the new Therapeutic Discovery Project Program limits awards to $5 million per company, but actual awards are expected to be lower due to number of applicants.

Valuation Watch: As Biopharma IPOs Return, Does Value?

At least a dozen companies that roughly fit the description of a venture-backed, R&D focused biotech or small pharmaceutical company have gone public since mid-2009. Here we look at how valuations stack up compared to M&A and previous IPO windows.

Health Care Reform: For Biopharmas There Is Much To Like

The passage of health reform was a momentous juncture for the health care industry, but is also just the beginning of years of policy development that amend or define the crucial details of the 2010 proposals. Analysts are still tallying the reform bill's final cost to biopharma companies; even so, the industry stands to gain more it gives up with the landmark legislation's passing.

Related Companies

Related Deals

UsernamePublicRestriction

Register

OM013133

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel